ADINTREVIMAB
UNII 054Q5D7VZI

Substance Identification & Data

This profile provides standardized clinical and technical data for Adintrevimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 054Q5D7VZI.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2516243-54-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

054Q5D7VZI

CAS Registry Number

2516243-54-0

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ADINTREVIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C182620

National Cancer Institute reference terminology for clinical and research data.

INN ID

12026

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

KL-188

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Adintrevimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ADINTREVIMAB

Common Names & Synonyms

ADG 20 [WHO-DD]

ADINTREVIMAB [INN]

ADINTREVIMAB [USAN]

IMMUNOGLOBULIN G1 (435-LEUCINE,441-ALANINE), ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN) (HUMAN MONOCLONAL ADG20 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL ADG20 .LAMBDA.-CHAIN, DIMER

IMMUNOGLOBULIN G1-LAMBDA2, ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) SPIKE (S) GLYCOPROTEIN, RECEPTOR BINDING DOMAIN (RBD)), HOMO SAPIENS MONOCLONAL ANTIBODY; GAMMA1 HEAVY CHAIN HOMO SAPIENS (1-454) (VH (HOMO SAPIENS IGHV3-21*01 (88.8%) -(IGHD) -IGHJ4*01 (92.9%), CDR-IMGT (8.8.17) (26-33.51-58.97-113)) (1-124) -HOMO SAPIENS IGHG1*03, G1M3, NG1M1, G1V24 CH3 L107, S114 (CH1 R120 (221) (125-222), HINGE 1-15 (223-237), CH2 (238-347), CH3 E12 (363), M14 (365), M107>L (435), N114>A (441) (348-452), CHS (453-454)) (125-453)), (227-217')-DISULFIDE WITH LAMBDA2 LIGHT CHAIN HOMO SAPIENS (1'-218') (V-LAMBDA (HOMO SAPIENS IGLV1-40*01 (95.9%) -IGLJ1*01 (91.7%), CDR-IMGT (9.3.12) (26-34.52-54.91-102)) (1'-112') -HOMO SAPIENS IGLC2*01 (100%) (113'-218')); DIMER (233-233'':236-236'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, GLYCOFORM ALFA

Technical Codes

ADG20

ADG-20

External Clinical & Regulatory Resources

Previous UNII054NR2135Y

Next UNII054QW4ZAMU